Carbon dioxide laser ablation of cutaneous metastases from malignant melanoma
- 1 April 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 78 (4), 493-494
- https://doi.org/10.1002/bjs.1800780433
Abstract
Multiple cutaneous and superficial subcutaneous metastases from malignant melanoma in 30 patients were treated palliatively by carbon dioxide laser ablation when lesions were too numerous, too large or recurring too rapidly for multiple local excisions. The number of lesions per patient ranged from three to 250 (median 30). Patients were treated under local or general anaesthetic and as day cases or inpatients. After a median follow-up interval of 8 months fewer than 1 per cent of lasered metastases have recurred locally. Sixteen patients have developed cutaneous metastases at other sites requiring further treatment. Approximately 2000 lesions have been treated on 64 occasions. Patients reported little or no pain after the operation and required only simple dry dressings. Wounds were completely healed in 2–6 weeks with good cosmetic results. This simple and effective treatment is becoming an alternative to isolated limb perfusion.Keywords
Funding Information
- Ken Oliver Reasearch
This publication has 6 references indexed in Scilit:
- Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limbBritish Journal of Surgery, 1990
- Effect of smoke evacuation on limiting thermal damage when using the carbon dioxide laser for cutaneous surgeryPublished by SPIE-Intl Soc Optical Eng ,1990
- A Prospective Randomized Study of Regional Extremity Perfusion in Patients with Malignant MelanomaAnnals of Surgery, 1984
- Objective Regression of Unexcised Melanoma in-Transit Metastases After Hyperthermic Isolation Perfusion of the Limbs with MelphalanPublished by Springer Nature ,1983
- Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbsEuropean Journal of Cancer (1965), 1981
- Isolated limb perfusion with melphalan in the treatment of malignant melanomaBritish Journal of Surgery, 1980